Product Information

BUPROPION HCL SR 100 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.0704 per EA under NDC 31722006660. Its NADAC has been published 143 times since Feb 21, 2024.

FDA first approved this application on May 31, 2023. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BUPROPION HCL SR 100 MG TABLET

Bupropion hydrochloride
$0.0704per EA

Strength

100 mg/1

NDC

31722006660

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA216800

FDA Approved

5/31/2023

TE Code

AB1

On Market Since

5/31/2023

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL SR 100 MG TABLET has been published 143 times since Feb 21, 2024, and over the history we have for it it has declined 25.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0704 per EA
All-time high$0.1012 (Apr 16, 2025)
All-time low$0.0639 (Oct 22, 2025)
52-week high$0.0752
52-week low$0.0661
Median price$0.0752
Average price$0.0798
Largest weekly change+30.2% (Jun 19, 2024)
Weeks tracked143
Tracking sinceFeb 21, 2024

Price History

1W

0.0%

1M

+3.7%

3M

+2.5%

6M

-4.9%

1Y

+10.3%

3Y

N/A

5Y

N/A

All

-25.6%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BUPROPION HCL SR 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 100 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.0704 per EA (NDC 31722006660), effective Nov 11, 2026.

How has the price of BUPROPION HCL SR 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL SR 100 MG TABLET has declined 25.6%. It has been tracked across 143 weekly CMS publications since Feb 21, 2024.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 100 MG TABLET?

Since Feb 21, 2024, the NADAC for BUPROPION HCL SR 100 MG TABLET has ranged from a low of $0.0639 (Oct 22, 2025) to a high of $0.1012 (Apr 16, 2025), with a median of $0.0752 per EA.

Are there cheaper alternatives to BUPROPION HCL SR 100 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUPROPION HCL SR 100 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures BUPROPION HCL SR 100 MG TABLET?

BUPROPION HCL SR 100 MG TABLET (NDC 31722006660) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.